0

Journal Articles

in Comparative Effectiveness Research
 41-44 of 44 Articles
Invited Critique | 
Elliott R. Haut, MD
Arch Surg. 2010;145(10):945-946. doi:10.1001/archsurg.2010.187.

Original Article |  FREE
Mark R. Hemmila, MD; Nancy J. Birkmeyer, PhD; Saman Arbabi, MD, MPH; et al.
Arch Surg. 2010;145(10):939-945. doi:10.1001/archsurg.2010.193.

Invited Critique | 
John D. Birkmeyer, MD
Arch Surg. 2010;145(4):328. doi:10.1001/archsurg.2010.19.

Editorial | 
David R. Urbach, MD, MSc; Arden M. Morris, MD, MPH
Arch Surg. 2010;145(2):120-122. doi:10.1001/archsurg.2009.264.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Viewpoint  | 
Ethics, Regulation, and Comparative Effectiveness Research:  Time for a Change
Richard Platt, MD, MS; Nancy E. Kass, ScD; Deven McGraw, JD, LLM, MPH
JAMA
Original Investigation  | 
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Paul Muntner, PhD; Lisandro D. Colantonio, MD; Mary Cushman, MD; et al.
JAMA
Original Investigation  | 
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor:  A Meta-analysis
June-Koo Lee, MD; Seokyung Hahn, PhD; Dong-Wan Kim, MD, PhD; et al.
JAMA
Viewpoint  | 
The Imperative of Overcoming Barriers to the Conduct of Large, Simple Trials
Zubin J. Eapen, MD, MHS; Michael S. Lauer, MD; Robert J. Temple, MD